investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mayo Clinic SPORE in Ovarian Cancer
Scott H Kaufmann
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Scott H Kaufmann
Mayo Clinic (Rochester)
Rochester, United States
Related projects
Ernst Lengyel
Regulation of Adhesion and Proteolysis in Ovarian Cancer
Ovary
Pathology
Kunle O Odunsi
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity
Ovary
Pathology
Joanne S. Richards
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
Ovary
Pathology
Shelley S Tworoger
Psychological Stress, Associate Biologic Mediators, and Ovarian Cancer Risk
Ovary
Pathology
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology
Simon A Gayther
The Contribution of Rare Alleles to Ovarian Cancer in the Population
Ovary
Pathology
Lesley M Butler
Urinary Metalloproteinases and Ovarian Cancer Risk in a Prospective Cohort
Ovary
Pathology
Bryan Q Spring
Online monitoring and image-guided treatment of chemoresistant micrometastases
Ovary
Pathology
Andre Michael Lieber
Evaluation of Vectors Based on Group B Adenoviruses
Ovary
Pathology
